Thyrocare Technologies Limited (BOM:539871)
387.85
-4.75 (-1.21%)
At close: Apr 21, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 61.73 billion as of April 22, 2026. Its market cap has increased by 66.24% in one year.
Market Cap
61.73B
Enterprise Value
60.05B
Revenue
7.92B
Ranking
n/a
PE Ratio
44.31
Stock Price
387.85
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 61.73B, an increase of 85.93%. That is a compound annual growth rate of 6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 61.73B | -13.04% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 11.56B |
| Chandan Healthcare | 6.23B |
| Star Imaging and Path Lab | 1.32B |
| Modern Diagnostic & Research Centre | 1.17B |
| Invicta Diagnostic | 980.61M |
| Aspira Pathlab & Diagnostics | 576.51M |
| Family Care Hospitals | 172.85M |
| Clinitech Laboratory | 103.85M |